MNCs lead price cuts in China’s second round of centralized procurement

MNC originators took the deepest price cuts in the second round of China’s expanded centralized procurement program for generic and off-patent drugs.

A list released Tuesday by China’s Joint Procurement Office showed that 77 winning bidders for 32 drugs agreed to average price cuts of 53%, with discounts as high as 93%, in exchange for guaranteed market share. ...